Welcome to our dedicated page for 1stdibs.com news (Ticker: $DIBS), a resource for investors and traders seeking the latest updates and insights on 1stdibs.com stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 1stdibs.com's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 1stdibs.com's position in the market.
1stdibs.com, Inc. (NASDAQ: DIBS) reported their first quarter financial results for 2024, showcasing a decrease in net revenue to $22.1 million (1% YoY decrease), an increase in gross profit to $16.0 million (7% YoY increase), and a decrease in GAAP net loss to $3.3 million compared to $8.1 million in Q1 2023. The company's gross margin improved to 72.5%, and their Cash, cash equivalents, and short-term investments totaled $134.2 million as of March 31, 2024.
The CEO highlighted progress against key goals, with improvements in demand metrics, conversion rates, GMV, and order growth. The CFO noted a stronger financial foundation, with improved take rates, expanded gross margins, lower operating expenses, and higher Adjusted EBITDA Margins.
However, some metrics saw declines, such as GMV at $91.7 million (6% YoY decrease), number of orders at approximately 35K, and active buyers at approximately 61K (9% YoY decrease).
The Company's Q2 2024 guidance includes GMV of $85 million - $92 million, net revenue of $21.0 million - $22.3 million, and Adjusted EBITDA margin of (14%) - (9%).